Lanzhou Biotechnique Development (LBD)
China · Pharma & Healthcare
LeaveRussia detail: Continue Operations
Decision trail
Decision date 01/07/2024 · Reference ↗
Binnopharm Group will begin sales in Russia of the botulinum toxin Lantox from the Chinese Lanzhou Biotechnique Development (LBD) in August 2024.
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional